For example, the importance of the fractalkine/CX3CR1 pathway in neurological disorders has been assessed using an animal model wherein the cx3cr1 gene is substituted with the gene for the green fluorescent protein (GFP) producing a defective receptor for fractalkine [11]. This evidence concerns the gene CX3CL1 and nervous system disorder.